Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Artificial Blood Market: By Product Type, By Application, By Distribution Channel, and Country
Europe Artificial Blood Market: By Product Type, By Application, By Distribution Channel, and Country
Europe Artificial Blood Market size was valued at US$ X million in 2023 and is poised to grow at a CAGR of X% from 2024-2030 Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to inadequate number of blood donors leads to shortage of blood. However, there are adverse effects associated with the artificial blood such as hemoglobin based blood substitute might increase the occurrence of heart attacks.
Increase in the prevalence of anemia and other blood disorders Rise in R&D for the innovation of newer products Increase in healthcare expenditure and well developed healthcare infrastructure Restraints: Lower shelf-life and instability of artificial blood Adverse effects associated with artificial blood substitutes Stringent regulatory guidelines for product approval
|
Report Benchmarks |
Details |
|
By Product type |
|
|
By Application |
|
|
By Distribution Channel |
|
Download Free Sample Report
The europe artificial blood market size was valued at US$ X million in 2023 and is poised to grow at a CAGR of x from 2024-2030
The report europe artificial blood market covers market data: Europe (Germany, France, Italy, Spain, and United Kingdom (UK),
The europe artificial blood market key players are aurum biosciences , hemarina , hemoglobin oxygen therapeutics llc , kalocyte inc. spheritech ltd. centrum medyczne visusmed european medicines agency opk biotech inc. nuvox pharma prolong pharmaceuticals, llc boston pharmaceuticals , oxyvita inc , nanoblood llc
| 1.Executive Summary |
| 2. Europe Artificial Blood Market Introduction |
| 2.1. Europe Artificial Blood Market - Taxonomy |
| 2.2. Europe Artificial Blood Market - Definitions |
| 2.2.1.Product type |
| 2.2.2.Application |
| 2.2.3.Distribution Channel |
| 2.2.4.Country |
| 3. Europe Artificial Blood Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Artificial Blood Market Analysis, 2019- 2023 and Forecast 2024 -2030 |
| 4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Artificial Blood Market By product type, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 5.1. Hemoglobin-Based Oxygen Carriers |
| 5.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Perflurocarbon-Based Products |
| 5.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Factors |
| 5.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Synthetic Platelets |
| 5.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Plasma Expanders |
| 5.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Europe Artificial Blood Market By product type, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 6.1. Traumatic Injuries |
| 6.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Blood Disorders |
| 6.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Anemia |
| 6.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Surgeries |
| 6.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Europe Artificial Blood Market By Distribution Channel, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Blood Banks |
| 7.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Europe Artificial Blood Market By Country, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 8.1. Germany |
| 8.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. France |
| 8.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Italy |
| 8.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. United Kingdom (UK) |
| 8.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Spain |
| 8.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9.Germany Europe Artificial Blood Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 9.1. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hemoglobin-Based Oxygen Carriers |
| 9.1.2.Perflurocarbon-Based Products |
| 9.1.3.Recombinant Factors |
| 9.1.4.Synthetic Platelets |
| 9.1.5.Plasma Expanders |
| 9.1.6.Others |
| 9.2. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Traumatic Injuries |
| 9.2.2.Blood Disorders |
| 9.2.3.Anemia |
| 9.2.4.Surgeries |
| 9.2.5.Others |
| 9.3. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinics |
| 9.3.3.Blood Banks |
| 10.Europe Europe Artificial Blood Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 10.1. product type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hemoglobin-Based Oxygen Carriers |
| 10.1.2.Perflurocarbon-Based Products |
| 10.1.3.Recombinant Factors |
| 10.1.4.Synthetic Platelets |
| 10.1.5.Plasma Expanders |
| 10.1.6.Others |
| 10.2. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Traumatic Injuries |
| 10.2.2.Blood Disorders |
| 10.2.3.Anemia |
| 10.2.4.Surgeries |
| 10.2.5.Others |
| 10.3. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Blood Banks |
| 11.France Europe Artificial Blood Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 11.1. product type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hemoglobin-Based Oxygen Carriers |
| 11.1.2.Perflurocarbon-Based Products |
| 11.1.3.Recombinant Factors |
| 11.1.4.Synthetic Platelets |
| 11.1.5.Plasma Expanders |
| 11.1.6.Others |
| 11.2. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Traumatic Injuries |
| 11.2.2.Blood Disorders |
| 11.2.3.Anemia |
| 11.2.4.Surgeries |
| 11.2.5.Others |
| 11.3. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Blood Banks |
| 12.Italy Europe Artificial Blood Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 12.1. product type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hemoglobin-Based Oxygen Carriers |
| 12.1.2.Perflurocarbon-Based Products |
| 12.1.3.Recombinant Factors |
| 12.1.4.Synthetic Platelets |
| 12.1.5.Plasma Expanders |
| 12.1.6.Others |
| 12.2. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Traumatic Injuries |
| 12.2.2.Blood Disorders |
| 12.2.3.Anemia |
| 12.2.4.Surgeries |
| 12.2.5.Others |
| 12.3. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Blood Banks |
| 13.United Kingdom (UK) Europe Artificial Blood Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 13.1. product type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hemoglobin-Based Oxygen Carriers |
| 13.1.2.Perflurocarbon-Based Products |
| 13.1.3.Recombinant Factors |
| 13.1.4.Synthetic Platelets |
| 13.1.5.Plasma Expanders |
| 13.1.6.Others |
| 13.2. product type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Traumatic Injuries |
| 13.2.2.Blood Disorders |
| 13.2.3.Anemia |
| 13.2.4.Surgeries |
| 13.2.5.Others |
| 13.3. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Blood Banks |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Aurum Biosciences , |
| 14.2.2.HEMARINA , |
| 14.2.3.Hemoglobin Oxygen Therapeutics LLC , |
| 14.2.4.KaloCyte Inc. |
| 14.2.5.SpheriTech Ltd. |
| 14.2.6.Centrum Medyczne VisusMed |
| 14.2.7.European Medicines Agency OPK Biotech Inc. |
| 14.2.8.NuvOx Pharma |
| 14.2.9.Prolong Pharmaceuticals, |
| 14.2.10. Boston Pharmaceuticals , |
| 14.2.11.OXYVITA Inc , |
| 14.2.12.NanoBlood LLC |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.